Skip to content

Cognition and Bimanual Performance in Children with Unilateral Cerebral Palsy

Cognition and Bimanual Performance in Children with Unilateral Cerebral Palsy

Status
Completed
Phases
Unknown
Study type
Observational
Source
ANZCTR
Registry ID
ACTRN12614000631606
Enrollment
131
Registered
2014-06-13
Start date
2013-01-25
Completion date
2015-08-14
Last updated
2020-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Brief summary

This project is a cross-sectional observational study examining the association between and among cognition, type and severity of brain injury and upper limb bimanual performance in a large sample of children (n=150), aged 6 to 12 years, with unilateral CP. The project will be conducted across 5 Australian sites specializing in the management of children with CP. The aim of this Project is to: (a) describe the association between and among cognition and upper limb bimanual performance in children with unilateral CP; (b) describe the association between and among cognition and upper limb bimanual performance and type and severity of brain injury in children with unilateral CP.

Interventions

Not applicable: Observational study. Eligible children will be assessed on a single occasion using a range of outcome measures relating to upper limb bimanual performance, motor planning, neuropsychological function and static magnetic resonance imaging (MRI).

Sponsors

Monash Children's Hospital
Lead SponsorHospital

Eligibility

Sex/Gender
All
Age
6 Years to 12 Years
Healthy volunteers
No

Inclusion criteria

1. Diagnosis of congenital unilateral cerebral palsy as diagnosed and reported in the medical history by a medical specialist (i.e. neurologist, paediatrician); 2. Age 6 to 12 years at the time of recruitment. 3. Sufficient cooperation to complete the assessments (ie. Ascent).

Exclusion criteria

1. Upper limb surgery within 12 months of assessment. 2. Injection of Botulinum toxin-A within 3 months of assessment.

Outcome results

None listed

Source: ANZCTR · Data processed: Mar 6, 2026